Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$513M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$412M |
| 3 |
Meta Platforms (Facebook)
META
|
+$354M |
| 4 |
ServiceNow
NOW
|
+$262M |
| 5 |
American Airlines Group
AAL
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$571M |
| 2 |
Apple
AAPL
|
+$571M |
| 3 |
Netflix
NFLX
|
+$388M |
| 4 |
NVIDIA
NVDA
|
+$313M |
| 5 |
TSMC
TSM
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.32% |
| 2 | Healthcare | 15.28% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 11.11% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
NexGel
NXGL
$3.6M
| $243K | ﹤0.01% |
81,631
-76,700
| -48% | -$249K |
|
3002
Olema Pharmaceuticals
OLMA
$1.05B
| $243K | ﹤0.01% |
64,600
-92,700
| -59% | -$466K |
|
3003
Vanguard FTSE All-World ex-US ETF
VEU
$68.4B
| $243K | ﹤0.01% |
4,000
-36,600
| -90% | -$2.21M |
|
|
AVNS
3004
DELISTED
Avanos Medical
AVNS
| $242K | ﹤0.01% |
+16,900
| New | +$264K |
|
3005
State Street SPDR S&P Insurance ETF
KIE
$641M
| $242K | ﹤0.01% |
4,000
-43,600
| -92% | -$2.54M |
|
3006
Live Ventures
LIVE
$30.1M
| $242K | ﹤0.01% |
31,699
-2,100
| -6% | -$17.9K |
|
3007
Lisata Therapeutics
LSTA
$9.74M
| $241K | ﹤0.01% |
102,722
+1,400
| +1% | +$3.79K |
|
3008
BrightView Holdings
BV
$1.07B
| $241K | ﹤0.01% |
+18,800
| New | +$269K |
|
3009
Kyverna Therapeutics
KYTX
$481M
| $241K | ﹤0.01% |
124,958
+80,258
| +180% | +$237K |
|
|
DM
3010
DELISTED
Desktop Metal, Inc.
DM
| $239K | ﹤0.01% |
48,762
-1,500
| -3% | -$3.88K |
|
3011
Tango Therapeutics
TNGX
$4.42B
| $239K | ﹤0.01% |
174,500
+153,000
| +712% | +$376K |
|
3012
EverCommerce
EVCM
$1.88B
| $239K | ﹤0.01% |
23,700
+1,500
| +7% | +$15.3K |
|
3013
The Beachbody Company
BODI
$75.5M
| $239K | ﹤0.01% |
31,864
+400
| +1% | +$2.87K |
|
|
SSY
3014
DELISTED
SunLink Health Systems
SSY
| $238K | ﹤0.01% |
238,278
-200
| -0.1% | -$191 |
|
3015
Telesat
TSAT
$885M
| $237K | ﹤0.01% |
+12,600
| New | +$241K |
|
3016
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.28B
| $237K | ﹤0.01% |
3,100
-3,700
| -54% | -$288K |
|
3017
Harte-Hanks
HHS
$16.9M
| $237K | ﹤0.01% |
49,284
-22,216
| -31% | -$113K |
|
3018
Beam Therapeutics
BEAM
$2.83B
| $236K | ﹤0.01% |
12,107
-10,800
| -47% | -$283K |
|
3019
First Seacoast Bancorp
FSEA
$80.1M
| $236K | ﹤0.01% |
20,232
+1,200
| +6% | +$12.8K |
|
3020
iShares MSCI KLD 400 Social ETF
DSI
$5.55B
| $236K | ﹤0.01% |
2,300
-12,800
| -85% | -$1.4M |
|
|
SGMA
3021
DELISTED
Sigmatron International
SGMA
| $235K | ﹤0.01% |
188,281
-11,664
| -6% | -$17.3K |
|
|
GLDG
3022
GoldMining Inc
GLDG
$217M
| $235K | ﹤0.01% |
276,770
+117,163
| +73% | +$95.5K |
|
3023
Rush Enterprises Class A
RUSHA
$6.27B
| $235K | ﹤0.01% |
4,400
-158,000
| -97% | -$9.06M |
|
3024
Transcontinental Realty Investors
TCI
$350M
| $235K | ﹤0.01% |
8,400
| – | – |
|
3025
Achieve Life Sciences
ACHV
$672M
| $235K | ﹤0.01% |
87,886
+26,726
| +44% | +$83.1K |
|
Similar funds
Renaissance Technologies's Q1 2025 Portfolio in Review
As of Q1 2025, Renaissance Technologies held 3,989 positions worth $66.1B, down 2.2% from $67.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2025 filing shows 456 new, 1,472 increased, 1,441 reduced and 583 closed positions. Its largest new stake was ServiceNow: 1,361,505 shares worth $217M. The largest sale was Palantir, an estimated $571M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2025 buy was ServiceNow: 1,361,505 shares worth $217M.
- Renaissance Technologies added most to Broadcom in Q1 2025, an estimated $513M increase.
- Renaissance Technologies's biggest Q1 2025 reduction was Palantir, cutting an estimated $571M.
- Renaissance Technologies fully exited Nike in Q1 2025, selling an estimated $197M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.1B portfolio in Q1 2025.
- Renaissance Technologies opened 456 new positions and closed 583 in Q1 2025.
- Renaissance Technologies's portfolio value fell 2.2% quarter-over-quarter to $66.1B.
Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.